|
SLFN11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.633900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.939600E-01 |
| Normal-vs-Stage2 |
1.428820E-01 |
| Normal-vs-Stage3 |
1.412970E-01 |
| Normal-vs-Stage4 |
2.305400E-01 |
| Stage1-vs-Stage2 |
2.900400E-01 |
| Stage1-vs-Stage3 |
2.558200E-01 |
| Stage1-vs-Stage4 |
2.830400E-01 |
| Stage2-vs-Stage3 |
9.735600E-01 |
| Stage2-vs-Stage4 |
4.785600E-01 |
| Stage3-vs-Stage4 |
4.689400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.741700E-02 |
| Normal-vs-AfricanAmerican |
7.052300E-02 |
| Normal-vs-Asian |
8.866600E-01 |
| Caucasian-vs-AfricanAmerican |
4.235400E-01 |
| Caucasian-vs-Asian |
7.393400E-01 |
| AfricanAmerican-vs-Asian |
5.739000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.253600E-01 |
| Normal-vs-Female |
5.055100E-03 |
| Male-vs-Female |
3.252200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.082600E-01 |
| Normal-vs-Extreme_Weight |
5.675000E-01 |
| Normal-vs-Obese |
6.201700E-02 |
| Normal-vs-Extreme_Obese |
9.182600E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.934400E-01 |
| Normal_Weight-vs-Obese |
6.987600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.979000E-03 |
| Extreme_Weight-vs-Obese |
1.824160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.239400E-03 |
| Obese-vs-Extreme_Obese |
4.599400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.549800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.776000E-03 |
| Normal-vs-Age(61-80Yrs) |
6.454800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.061800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.620200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.250400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.294600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.557600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.126000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.361200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.097000E-01 |
| Normal-VS-Type2 PRCC |
5.436400E-02 |
| Normal-VS-KIRP CIMP |
2.501700E-02 |
| Normal-VS-Unclassified PRCC |
8.758300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.129560E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.058320E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.514170E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.191400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.539980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.631000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.849900E-02 |
| Normal-vs-N1 |
5.369800E-02 |
| Normal-vs-N2 |
3.440400E-01 |
| N0-vs-N1 |
2.385400E-01 |
| N0-vs-N2 |
4.831400E-01 |
| N1-vs-N2 |
7.862200E-01 |
|
|
